Extraction method and application of magnetic chitosan and sulfachloropyridazine in milk source
By using magnetic chitosan as a solid phase column, combined with enzymatic lysis and eluent, the problem of high cost of solid phase purification columns in the prior art is solved, and the efficient extraction and detection of sulfachlorodylazine in milk is achieved, thus achieving the The spike recovery rate of 93.4% reduces the detection cost.
Patent Information
- Application Number
- CN202411183409.1
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-08-27
- Publication Date
- 2024-11-12
AI Technical Summary
In the prior art, when detecting the residue of sulfachloropyridazine in animal emulsions, the use of solid-phase purification columns is costly and consumables are disposable, making it difficult to achieve efficient and low-cost extraction and detection.
Magnetic chitosan is used as a solid phase column to prepare the first magnetic chitosan by mixing reaction with acid solution and Fe2+ and Fe3+ salts, and react with a crosslinking agent to prepare the second magnetic chitosan for sulfonamide in milk. Extraction and detection of chlorpyridazine, combined with enzymatic lysis and eluent for efficient extraction and recovery.
The efficient extraction and detection of sulfachlorodylazine was achieved, and the spiking recovery rate reached 93.4%, reducing the detection cost and providing a low-cost and efficient emulsion residue detection method.
Smart Images

Figure BDA0005012857150000061 
Figure BDA0005012857150000062 
Figure BDA0005012857150000081
Abstract
Description
Technical Field
[0001] The invention belongs to the technical field of emulsion residue detection, and particularly relates to a magnetic chitosan and a method for extracting sulfachloropyridazine from milk sources and application thereof. Background Art
[0002] Sulfadiazine is a sulfonamide drug with a broad-spectrum antibacterial effect, commonly used in the prevention and treatment of livestock and poultry diseases. However, sulfadiazine will remain in the body of animals, and the sulfadiazine residues in the animal body will be secreted into the milk and then absorbed by humans. Sulfadiazine residues can cause allergic reactions in some people. In mild cases, they may manifest as urticaria, fever, joint swelling and pain, etc. In severe cases, anaphylactic shock may occur, and even life-threatening; and long-term low-dose absorption of sulfadiazine residues may lead to an increase in drug-resistant bacteria in the human body, making antibiotics less effective or ineffective in the treatment of infectious diseases; in addition, sulfadiazine residues may inhibit or kill sensitive bacteria, leading to an imbalance in the gastrointestinal flora, thereby causing infectious diseases.
[0003] Therefore, in order to ensure food safety and human health, countries have set strict limit standards for the residues of antibiotics such as sulfachloropyridazine in animal milk. For example, according to publicly released information, the detection limit of sulfa drugs such as sulfachloropyridazine in milk is usually at a low microgram per kilogram level (such as 1.0ug / kg) to ensure that the antibiotic residues in the milk consumed by consumers are within a safe range.
[0004] At present, most of the detection standards for sulfachloropyridazine in animal emulsions (such as "GB / T22966-2008") use solid phase purification columns and organic solvents such as n-hexane, acetonitrile, and ethyl acetate. Solid phase purification columns are consumables and can only be used once, with high usage costs. Summary of the invention
[0005] The invention develops a magnetic chitosan, which can be used as a solid phase column and combined with an eluent to extract sulfachloropyridazine in milk (after protein treatment), and the subsequent detection of sulfachloropyridazine can achieve a spiked recovery rate of 89%. The preparation method of the magnetic chitosan is simple and has low cost.
[0006] In order to achieve the above object, the present invention can adopt the following technical solutions:
[0007] The present invention provides a magnetic chitosan, wherein the preparation method comprises: (1) mixing an acid solution containing chitosan, Fe 2+ Salt and Fe 3+ The salts are mixed and dissolved to obtain a mixture; (2) the mixture is mixed and reacted with an alkaline solution to obtain a first magnetic chitosan.
[0008] Preferably, the preparation method may further include: mixing the first magnetic chitosan with a chitosan cross-linking agent to obtain a second magnetic chitosan.
[0009] Preferably, the chitosan cross-linking agent is selected from one or more combinations of glutaraldehyde, formaldehyde and glyoxal.
[0010] Another aspect of the present invention provides a method for extracting sulfachloropyridazine from milk, comprising: (1) enzymatically hydrolyzing the milk to obtain a treatment solution; (2) adding magnetic chitosan to the treatment solution for extraction to obtain an extract containing sulfachloropyridazine; wherein the magnetic chitosan is the magnetic chitosan in the present invention.
[0011] Preferably, the elution comprises: mixing the magnetic chitosan with the treatment solution, vortexing, removing the supernatant to obtain a residue; and mixing the residue with an eluent to obtain an extract by elution.
[0012] Preferably, the above extraction includes one or more combinations of the following conditions: (a) the eluent is a mixed solution of perchloric acid and methanol; (b) the eluent is a mixed solution of perchloric acid and methanol, wherein the mass fraction of perchloric acid is 0.05%-0.15%; (c) the eluent is a mixed solution of perchloric acid and methanol, wherein the volume ratio of perchloric acid to methanol is (17-21):1; (d) the amount of magnetic chitosan is 80mg-120mg; (e) the amount of the eluent is 5mL-10mL.
[0013] Preferably, the extraction comprises one or more combinations of the following conditions: (a) the vortex oscillation time is ≥20 min; (b) the vortex oscillation temperature is 23°C-27°C; (c) the elution comprises: ultrasonic oscillation and filtration of the mixture after the residue and the eluent are mixed; the temperature of the ultrasonic oscillation is 40°C-50°C; (d) the elution comprises: ultrasonic oscillation and filtration of the mixture after the residue and the eluent are mixed; the ultrasonic oscillation time is ≥20 min.
[0014] Preferably, the enzymatic hydrolysis comprises: using a protease to perform enzymatic hydrolysis.
[0015] In another aspect, the present invention provides a method for detecting the content of sulfachloropyridazine in milk source, comprising: (1) extracting milk source according to the extraction method of the present invention to obtain an extract containing sulfachloropyridazine; and (2) detecting the content of sulfachloropyridazine in the extract containing sulfachloropyridazine.
[0016] Preferably, in the above detection method, LC / MS / MS is used to detect the sulfachloropyridazine content in the extract containing sulfachloropyridazine.
[0017] The beneficial effects of the present invention include at least:
[0018] (1) The magnetic chitosan provided by the present invention can be used as a solid purification column for eluting sulfachloropyridazine. The preparation method of the magnetic chitosan is simple, the raw materials are cheap, and the cost is lower than that of the solid purification column in the existing national standard.
[0019] (2) Based on the extraction method of sulfachloropyridazine in milk provided by the present invention, sulfachloropyridazine was spiked and tested, and the spiked recovery rate could reach 93.4%. DETAILED DESCRIPTION
[0020] The examples are provided to better illustrate the present invention, but the present invention is not limited to the examples. Therefore, those skilled in the art may make non-essential improvements and adjustments to the implementation scheme according to the above invention content, which still fall within the protection scope of the present invention.
[0021] The terms used herein are only used to describe specific embodiments and are not intended to limit the present disclosure. Unless the context has a significantly different meaning, expressions in the singular include expressions in the plural. As used herein, it should be understood that terms such as "include", "have", "include" are intended to indicate the presence of features, numbers, operations, materials, or combinations. The terms of the present invention are disclosed in the specification, and are not intended to exclude the possibility that one or more other features, numbers, operations, materials, or combinations thereof may exist or may be added. As used herein, " / " may be interpreted as "and" or "or", depending on the circumstances.
[0022] The present invention provides a magnetic chitosan, wherein the preparation method comprises: (1) mixing an acid solution containing chitosan, Fe 2+ Salt and Fe 3+ The salts are mixed and dissolved to obtain a mixture; (2) the mixture is mixed with an alkaline solution to react to obtain a first magnetic chitosan.
[0023] It should be noted that the chitosan acid solution in the present invention is a solution formed by dissolving chitosan in an acid, and the acid may be an acid known in the art, such as formic acid or acetic acid, preferably acetic acid, which is more conducive to the reaction in the present invention; in addition, Fe 2+ Salt and Fe 3+ The salt may be any salt known in the art, such as Fe 2+ The salt can be ferrous sulfate, Fe 3+The salt may be ferric chloride, etc. In addition, the alkaline solution in the present invention is also well known in the art, such as sodium hydroxide solution; in addition, it should be understood that the above preparation method may also include heating, washing or drying processes to increase the reaction rate or improve the purity of the product, which can be selected according to specific needs; for example, the heating temperature may be 80°C-100°C, and stirring may be performed during the heating for 1.5h-2h; washing may be performed with pure water until neutral; in addition, in order to control the reaction rate, the mixture is mixed with the alkaline solution by dropping the alkaline solution.
[0024] In some specific examples, the preparation method may further include: mixing the first magnetic chitosan with a chitosan cross-linking agent to obtain a second magnetic chitosan.
[0025] It should be noted that the first magnetic chitosan in the present invention can also be cross-linked with glutaraldehyde to prepare a second magnetic chitosan. The second magnetic chitosan has a better extraction efficiency of sulfachloropyridazine in milk than the first magnetic chitosan.
[0026] In some specific examples, the chitosan cross-linking agent may be selected from one or more combinations of glutaraldehyde, formaldehyde and glyoxal.
[0027] It should be noted that the chitosan crosslinking agent is a crosslinking agent known in the art, such as an aldehyde crosslinking agent or a phthalocyanine crosslinking agent. In the present invention, an aldehyde crosslinking agent is preferred, and one or more combinations of glutaraldehyde, formaldehyde and glyoxal are more preferred, as the crosslinking effect is better.
[0028] The embodiment of the present invention also provides a method for extracting sulfachloropyridazine from milk, which comprises: (1) enzymatically hydrolyzing the milk to obtain a treatment solution; (2) adding magnetic chitosan to the treatment solution for extraction to obtain an extract containing sulfachloropyridazine; wherein the magnetic chitosan is the magnetic chitosan in the present invention.
[0029] It should be noted that the first magnetic chitosan or the second magnetic chitosan prepared above can be used as a solid phase column to replace the existing solid phase column in the present invention, which saves costs, has excellent extraction efficiency, and has a high recovery rate of sulfachloropyridazine. In addition, the milk source in the present invention can be cow's milk, goat's milk or camel's milk.
[0030] In some specific examples, the extraction may include: mixing the magnetic chitosan with the treatment solution, vortexing, removing the supernatant to obtain a residue; and mixing the residue with an eluent to obtain an extract.
[0031] It should be noted that the elution method in the present invention can be a method known in the art, preferably the above-mentioned extraction method, in which each operation step is an operation step known in the art; in addition, elution is an elution method known in the art.
[0032] In some specific examples, the above extraction includes one or more combinations of the following conditions:
[0033] (a) the eluent is a mixed solution of perchloric acid and methanol; specifically, the eluent in the present invention may preferably be a mixed solution of perchloric acid and methanol, which is less toxic than the organic solvents such as n-hexane, acetonitrile, ethyl acetate, etc. currently used;
[0034] (b) the eluent is a mixed solution of perchloric acid and methanol, wherein the mass fraction of perchloric acid is 0.05%-0.15%; specifically, the mass fraction of perchloric acid in the eluent may be 0.05%-0.15%, such as 0.07%, 0.1% or 0.12%;
[0035] (c) the eluent is a mixed solution of perchloric acid and methanol, wherein the volume ratio of perchloric acid to methanol is (17-21):1; specifically, the volume of perchloric acid and methanol has an influence on the elution effect, and in the present invention, (17-21):1 can be selected, such as 18:1, 19:1 or 20:1, etc., preferably 19:1, which has a better elution effect;
[0036] (d) The dosage of magnetic chitosan is 80mg-120mg; specifically, the residual amount of sulfachloropyridazine in the milk sample is very low, and according to the sample amount weighed in the method, the dosage of magnetic chitosan can ensure complete adsorption.
[0037] (e) The amount of the eluent is 5 mL-10 mL; specifically, the eluent is used to ensure that the adsorbed sulfachloropyridazine can be eluted out. In the present invention, 5 mL-10 mL can be selected, such as 6 mL, 7 mL or 9 mL.
[0038] In some specific examples, the elution includes one or more combinations of the following conditions:
[0039] (a2) vortex oscillation time ≥ 20 min; specifically, when the vortex oscillation time is ≥ 20 min, the adsorption and extraction efficiency of sulfachloropyridazine is significantly increased, which can reach 92.4%, but when the vortex oscillation time continues to increase, the adsorption and extraction efficiency is not greatly improved, so the vortex oscillation time in the present invention is ≥ 20 min, such as 25 min, 30 min, 35 min or 45 min, etc., more preferably 20 min;
[0040] (b2) the vortex oscillation temperature is 23°C-27°C (room temperature); specifically, the vortex oscillation temperature also has an effect on the adsorption and extraction efficiency of sulfachloropyridazine. When the temperature exceeds 27°C, the molecules become more active, destroying the intermolecular attraction, the adsorption force of the cross-linked magnetic chitosan decreases, and the adsorption efficiency decreases. Therefore, in the present invention, 23°C-27°C is selected, and the adsorption efficiency can reach 93.2%;
[0041] (c2) elution comprises: ultrasonically oscillating the mixture of the residue and the eluent, and filtering; the temperature of the ultrasonic oscillation is 40° C.-50° C.; specifically, the temperature of the ultrasonic oscillation has an effect on the recovery rate, when the temperature is less than 40° C., the recovery rate decreases significantly, when the temperature is from 40° C. to 50° C., the recovery rate does not change much, so in the present invention, 40° C.-50° C. is preferred, and the recovery rate can reach 92.7%;
[0042] (d2) Elution includes: ultrasonically oscillating the mixture of the residue and the eluent, and filtering; the ultrasonic oscillation time is ≥20 min; specifically, the ultrasonic oscillation time also affects the recovery rate. When the oscillation time is less than 20 min, the recovery rate decreases significantly. When the oscillation time is greater than 20 min, the recovery rate increases, but the increase is not significant. Therefore, 20 min is preferred in the present invention.
[0043] It should be understood that in chromatographic analysis, the final sample solution needs to be filtered with a filter membrane to remove macromolecular impurities in the solution before entering the chromatograph. The purpose is to prevent contamination of the chromatographic column, blockage of the chromatographic column and chromatographic flow path, and affect the test results. High-performance liquid chromatography generally requires a 0.45μm filter membrane, and mass spectrometers require a 0.22μm filter membrane.
[0044] In some specific examples, the enzymatic hydrolysis includes: performing enzymatic hydrolysis using a protease.
[0045] It should be noted that the egg precipitant in the present invention can be any protein precipitant known in the art, such as salts, alcohols or biological enzymes. In the present invention, biological enzymes are preferred, which can avoid the use of organic solvents and improve the subsequent recovery rate of sulfachloropyridazine. In addition, the enzymatic hydrolysis process is well known in the art, such as mixing milk source with protease, heating reaction, and filtering to obtain a treated liquid after enzymatic hydrolysis; of course, it should be understood that after enzymatic hydrolysis, enzyme inactivation treatment can be performed according to specific circumstances.
[0046] The embodiment of the present invention also provides a method for detecting the content of sulfachloropyridazine in milk source, which comprises: (1) extracting the milk source according to the extraction method of the present invention to obtain an extract containing sulfachloropyridazine; (2) detecting the content of sulfachloropyridazine in the extract containing sulfachloropyridazine.
[0047] It should be noted that, in the present invention, sulfachloropyridazine is extracted from the milk source based on the above extraction method and then detected, so that the sulfachloropyridazine content in the milk source can be detected, which reduces the drying of other substances in the milk source and improves accuracy.
[0048] In some specific examples, in the above detection method, LC / MS / MS is used to detect the content of sulfachloropyridazine in the extract containing sulfachloropyridazine.
[0049] It should be noted that, in the present invention, the method for detecting the content of sulfachloropyridazine in the extract containing sulfachloropyridazine can be a method known in the art, such as liquid chromatography-tandem mass spectrometry (LC / MS / MS).
[0050] In order to better understand the present invention, the content of the present invention is further explained below in conjunction with specific examples, but the content of the present invention is not limited to the following examples.
[0051] 1. Preparation of magnetic chitosan
[0052] Example 1
[0053] (1) Preparation of magnetic chitosan material: 1.65 g of ordinary chitosan (McLean) was dissolved in 75 mL of 3% acetic acid (acetic acid) solution, 2.7 g of FeCl3·6H2O and 1.39 g of FeSO4·7H2O were weighed and added to the chitosan acetic acid solution; the mixture was stirred at 40°C for 30 min under vacuum until all solids were dissolved; 25 mL of NaOH solution (144 g / L) was slowly added to the mixed solution through a dropping funnel, and after the addition, the mixture was heated to 90°C and stirred for 2 h, then washed with pure water until neutral, and dried at 70°C under vacuum overnight;
[0054] (2) Cross-linking of magnetic chitosan: Glutaraldehyde is added to the magnetic chitosan prepared in the above (1) (the magnetic chitosan is completely immersed in glutaraldehyde), vacuum magnetic stirring is performed for 2 hours, and the chitosan is washed with ethanol three times and then washed with pure water until neutral; the cross-linked magnetic chitosan is then dried in an oven to remove moisture to obtain cross-linked magnetic chitosan; in the case of an external magnet, the cross-linked magnetic chitosan can be quickly adsorbed by the magnet and has a good magnetic response.
[0055] Comparative Example 1
[0056] Ordinary chitosan (McLean) was used as comparative example 1.
[0057] Comparative Example 2
[0058] An existing solid purification column (Oasis HLB solid phase extraction column) was used as comparative example 2.
[0059] 2. Magnetic chitosan adsorption test
[0060] In the following tests, the specific parameters of LC / MS / MS determination are shown in Tables 1 to 4 below.
[0061] Table 1 Liquid chromatography parameters
[0062] Chromatographic columns C18, 5μm, 50mm×2.1mm (inner diameter) Column temperature 30℃ Injection volume 1uL Mobile phase gradient and flow rate Table 2
[0063] Table 2 Liquid chromatography gradient elution conditions
[0064] Time / min Flow rate / (mL / min) 0.1% acetic acid aqueous solution / % Methanol / % 0.00 0.2 75 25 5.00 0.2 55 45 6.00 0.2 20 80 8.00 0.2 20 80 10.00 0.2 75 25 11.00 0.2 75 25
[0065] Table 3 Mass spectrometry conditions
[0066]
[0067] Table 4 Sulfadiazine parent ion, qualitative ion pair, quantitative ion pair and collision energy
[0068]
[0069] (I) Determination of adsorption time
[0070] A standard solution of sulfachloropyridazine (10 ug / L) was prepared, and 5 portions of 100 mg of the cross-linked magnetic chitosan prepared in Example 1 were weighed and labeled as No. 1, No. 2, No. 3, No. 4 and No. 5, respectively. 1 mL of the 10 ug / L standard solution was respectively drawn into the magnetic chitosan, and the mixture was extracted by vortexing at 25° C. Tube No. 1 was vortexed for 1 min, tube No. 2 for 5 min, tube No. 3 for 10 min, tube No. 4 for 20 min, and tube No. 5 for 30 min. The supernatant was then drawn for LC / MS / MS determination, and the adsorption rate was calculated. The results are shown in Table 5 below.
[0071] Table 5 Adsorption rate at different vortex oscillation times
[0072] serial number Adsorption rate (%) No. 1 (1min) 29.8 No. 2 (5min) 53.3 No. 3 (10min) 78.7 No. 4 (20min) 92.4 No. 5 (30min) 93.1
[0073] It can be seen from Table 5 above that, from the perspective of adsorption rate, the longer the vortex oscillation time, the higher the adsorption rate. However, there is little improvement between vortex oscillation for 30 min and 20 min, indicating that after 20 min, the vortex oscillation time has little effect on the adsorption rate. Taking all factors into consideration, a vortex oscillation time of 20 min is preferred.
[0074] (II) Determination of the amount of magnetic chitosan
[0075] 20 mg, 50 mg, 100 mg and 200 mg of the cross-linked magnetic chitosan prepared in Example 1 were weighed into 4 different plastic centrifuge tubes, 1 mL of 10 ug / L sulfachloropyridazine standard solution was added, and the mixture was vortexed at 25° C. for 20 min. The supernatant was aspirated, filtered through a 0.22 um filter membrane, and then measured by LC / MS / MS to calculate the adsorption rate. The measurement results are shown in Table 6 below.
[0076] Table 6 Adsorption rate of different magnetic chitosan dosages
[0077] Amount of cross-linked magnetic chitosan (mg) Supernatant content ug / L Adsorption rate % 20 4.39 56.1 50 6.11 38.9 100 0.72 92.8 200 0.64 93.6
[0078] It can be seen from Table 6 above that the more the amount of magnetic chitosan is used, the higher the adsorption rate is. After the adsorption rate reaches 90%, the adsorption rate does not change much with increasing the amount of magnetic chitosan. Combined with the actual laboratory conditions and daily sample conditions, the amount of magnetic chitosan in the present invention is preferably 100 mg.
[0079] (III) Determination of adsorption temperature
[0080] Weigh 4 portions of 100 mg of the cross-linked magnetic chitosan prepared in Example 1 into 4 different plastic centrifuge tubes, add 1 mL of 10 ug / L sulfachloropyridazine standard solution to each tube, vortex and oscillate for 20 min at 25°C, 30°C, 40°C, and 50°C, then draw the supernatant, filter it through a 0.22 um filter membrane, and then provide it for LC / MS / MS determination. The adsorption rate was calculated. The results are shown in Table 7 below.
[0081] Table 7 Adsorption rate at different vortex oscillation temperatures
[0082] Adsorption temperature (℃) Supernatant content ug / L Adsorption rate % 25 0.68 93.2 30 1.42 85.8 40 3.59 64.1 50 5.06 49.4
[0083] It can be seen from Table 7 above that the higher the temperature, the lower the adsorption rate. This is mainly because the higher the temperature, the more active the molecules are, which destroys the intermolecular attraction and reduces the adsorption force of magnetic chitosan. The adsorption temperature is determined to be 25°C.
[0084] 3. Magnetic chitosan elution test
[0085] In the following tests, the specific parameters of LC / MS / MS determination are shown in Tables 1 to 4 above.
[0086] (I) Selection of eluent
[0087] Weigh 4 portions of 100 mg of the cross-linked magnetic chitosan prepared in Example 1 and place them in 4 different plastic centrifuge tubes, labeled as No. 1, No. 2, No. 3, and No. 4, respectively, add 1 mL of 10 ug / L sulfachloropyridazine standard solution to the centrifuge tubes, vortex and oscillate at 25° C. for 20 min, discard the supernatant under an external magnet, add different 5 mL of eluent to each centrifuge tube, and the theoretical content of sulfachloropyridazine in the eluent is 2 ug / L; 5 mL of methanol is added to tube No. 1, 5 mL of methanol-water mixed solution (methanol and water are mixed in a volume ratio of 1:1) is added to tube No. 2, 5 mL of ammonia-methanol solution (ammonia (mass fraction 25%-28%) and methanol in a volume ratio of 5:95) is added to tube No. 3, and 5 mL of 4 is added to tube No. 5. 0.1% perchloric acid + methanol solution (volume ratio 19:1), ultrasonic oscillation at 40°C for 20 minutes, the supernatant was filtered through a 0.22μm filter membrane and then subjected to LC / MS / MS determination to obtain the measured content of sulfachloropyridazine in the eluate, and the recovery rate was calculated. The recovery rate (recovery rate (%) = measured content of eluate ÷ theoretical content of eluate × 100%, the same below) was calculated according to the following formula. The results are shown in Table 8 below.
[0088] Table 8 Recovery rates of different eluents
[0089]
[0090] It can be seen from Table 8 above that pure methanol has almost no elution effect, ammonia methanol solution has almost no elution effect, and the elution rates of methanol and water are also very low. Combined with the magnetic chitosan adsorption principle, the addition of acid solution can destroy the attraction between the magnetic chitosan and sulfachloropyridazine molecules, so that the sulfachloropyridazine molecules are separated from the chitosan molecules and dissolved in the eluent. 0.1% perchloric acid + methanol solution (volume ratio 19:1) is used as the final eluent.
[0091] (II) Determination of elution temperature
[0092] Weigh 4 portions of 100 mg of the cross-linked magnetic chitosan prepared in Example 1 and place them in 3 different centrifuge tubes, labeled as No. 1, No. 2, No. 3, and No. 4, and add 1 mL of 10 ug / L sulfachloropyridazine standard solution, vortex oscillate at 25° C. for 20 min, discard the supernatant under an external magnet, remove the magnet, add 5 mL of 0.1% perchloric acid + methanol solution (volume ratio 19:1) to the centrifuge tube, ultrasonic oscillate No. 1 tube at 25° C. for 20 min, ultrasonic oscillate No. 2 tube at 30° C. for 20 min, ultrasonic oscillate No. 3 tube at 40° C. for 20 min, and ultrasonic oscillate No. 4 tube at 50° C. for 20 min, then draw the supernatant, filter through a 0.22 um filter membrane, and provide LC / MS / MS for determination to obtain the content of sulfachloropyridazine in the eluent, and calculate the recovery rate, which is calculated as follows; the results are shown in Table 9 below.
[0093] Table 9 Recovery rate at different elution temperatures
[0094]
[0095] It can be seen from Table 9 above that as the elution temperature increases, the recovery rate also increases. The recovery rate at 50°C is only 0.07% higher than that at 40°C. In the later stage, the effect of temperature on the recovery rate becomes smaller and smaller, and basically reaches a saturated state. Considering all factors, 40°C is the preferred elution temperature.
[0096] (III) Determination of elution time
[0097] Weigh 5 portions of 100 mg of the cross-linked magnetic chitosan prepared in Example 1 and put them into 5 different plastic centrifuge tubes, marked as No. 1, No. 2, No. 3, No. 4, and No. 5, respectively. Add 1 mL of 10 ug / L sulfachloropyridazine standard solution to each centrifuge tube, vortex for 20 min, discard the supernatant under an external magnet, add 5 mL of eluent to the plastic centrifuge tube, ultrasonically oscillate at 40° C., ultrasonically oscillate No. 1 tube for 5 min, ultrasonically oscillate No. 2 tube for 10 min, ultrasonically oscillate No. 3 tube for 20 min, ultrasonically oscillate No. 4 tube for 30 min, and ultrasonically oscillate No. 5 tube for 60 min. After filtering the supernatant through a 0.22 um filter membrane, provide LC / MS / MS determination to obtain the final amount of sulfachloropyridazine, and calculate the recovery rate. The results are shown in Table 10 below.
[0098] Table 10 Recovery rate at different elution times
[0099]
[0100] It can be seen from Table 10 above that at the beginning, as the elution time increases, the recovery rate also increases accordingly. However, after a certain time, the elution reaches an equilibrium, and the recovery rate hardly increases with increasing time. Based on the actual situation, the elution time is selected to be 20 minutes.
[0101] (IV) Determination of the amount of eluent
[0102] Weigh 4 portions of 50 mg of the cross-linked magnetic chitosan prepared in Example 1 into different plastic centrifuge tubes, marked as No. 1, No. 2, No. 3 and No. 4, respectively, and then add 1 mL of 10 ug / L sulfachloropyridazine standard solution, vortex oscillate at 25° C. for 20 min, discard the supernatant under an external magnet, remove the magnet, add 1 mL, 2 mL, 5 mL, and 10 mL of 0.1% perchloric acid + methanol solution (volume ratio 19:1) to the centrifuge tubes, ultrasonically oscillate at 40° C. for 20 min, filter the supernatant through a 0.22 um filter membrane, and measure it with LC / MS / MS to calculate the recovery. The results are shown in Table 11 below.
[0103] Table 11 Recovery rate of different eluent dosages
[0104]
[0105] It can be seen from Table 11 above that as the volume of the eluent increases, the recovery rate also increases. However, after the recovery rate reaches 90% (that is, after the amount of eluent reaches 5 mL), the increase in eluent has little effect on the recovery rate. Considering all factors, 5 mL of eluent is selected.
[0106] 4. Blank milk sample spike recovery test
[0107] In the following tests, the specific parameters of LC / MS / MS determination are shown in Tables 1 to 4 above.
[0108] In the following tests, the sample spike recovery rate test was carried out in accordance with the provisions of GB / T 27404-2008 "Laboratory Quality Control Specifications for Food Physical and Chemical Testing". The requirements for recovery rate in the standard are shown in Table 12 below.
[0109] Table 12 Requirements for recovery rate in the standard
[0110] Content of the tested component / (mg / kg) Recovery rate range / % >100 95-105 1-100 90-110 0.1-1 80-110 <0.1 60-120
[0111] In this test, a protein precipitant was first used to remove protein from milk, and then the cross-linked magnetic chitosan prepared in Example 1 was used to adsorb and elute sulfachloropyridazine in the solution; commonly used protein precipitants include inorganic salt solutions, organic solvents, acid solutions, proteases, and buffer solutions. This test selected three reagents, zinc sulfate aqueous solution + potassium ferrocyanide aqueous solution, anhydrous ethanol, and protease, to conduct sample spike experiments and select the best solution.
[0112] (I) Zinc sulfate aqueous solution + potassium ferrocyanide aqueous solution
[0113] Accurately weigh 1g of milk in a 10mL colorimetric tube, add 0.5mL of 100ug / L sulfachloropyridazine standard solution, weigh 7 groups in parallel for spiked parallel, the theoretical content in the milk sample is 0.05mg / kg (0.05mg / kg refers to the amount of sulfachloropyridazine added divided by the mass of the milk sample weighed, that is, 0.5mL*100ug / L÷1g÷1000=0.05mg / kg), first add 200uL of zinc sulfate aqueous solution, mix well, then add 200uL of potassium ferrocyanide aqueous solution, mix well, and dilute to 60% with water. 10mL; transferred to a centrifuge tube, centrifuged at 5000r / min for 5min, the supernatant was transferred to a plastic centrifuge tube containing 100mg of the cross-linked magnetic chitosan prepared in Example 1, vortexed for 20min, the supernatant was discarded under an external magnet, 50mL of 0.1% perchloric acid + methanol solution (volume ratio 19:1) was added to the centrifuge tube, ultrasonicated at 40°C for 20min, the supernatant was filtered through a 0.22μm filter membrane and then subjected to LC / MS / MS determination, and the spike recovery was calculated. The results are shown in Table 13 below.
[0114] Table 13 Recovery of zinc sulfate aqueous solution + potassium ferrocyanide aqueous solution as precipitant
[0115] Serial number Sulfadiazine results (mg / kg) Spiked recovery % 1 0.0174 34.0 2 0.0168 32.0 3 0.0159 30.0 4 0.0163 32.0 5 0.0184 36.0 6 0.0171 24.0 7 0.0166 32.0
[0116] It can be seen from Table 13 above that the spiked recovery rate after protein precipitation using zinc sulfate aqueous solution + potassium ferrocyanide aqueous solution is only 30%-36%, resulting in a low recovery rate. There are two main reasons: first, part of sulfachloropyridazine is embedded in the generated flocculent precipitate and is separated from the solution together with the precipitate after centrifugation; second, because the cross-linked magnetic chitosan prepared in Example 1 has the function of adsorbing metal ions, the precipitant contains zinc ions and potassium ions, which leads to the reduced ability of the cross-linked magnetic chitosan prepared in Example 1 to adsorb sulfachloropyridazine.
[0117] (ii) Anhydrous ethanol
[0118] Accurately weigh 1g of milk in a 25mL colorimetric tube, add 0.5mL100ug / L sulfachloropyridazine standard solution, and weigh 7 groups in parallel for spiked parallel, with a spiked content of 0.05mg / kg; dilute to 10mL with anhydrous ethanol, oscillate and mix, centrifuge at 5000r / min for 5min, transfer all the supernatant to a plastic centrifuge tube containing 100mg of the cross-linked magnetic chitosan prepared in Example 1, vortex oscillate for 20min, discard the supernatant under an external magnet, add 5mL0.1% perchloric acid + methanol solution (volume ratio 19:1) to the centrifuge tube, sonicate at 40°C for 20min, filter the supernatant through a 0.22μm filter membrane, and provide LC / MS / MS determination to calculate the recovery rate. The results are shown in Table 14 below.
[0119] Table 14 Spiked recovery of anhydrous ethanol as precipitant
[0120] Serial number Sulfadiazine results (mg / kg) Spiked recovery % 1 0.0233 46.6 2 0.0241 48.2 3 0.0238 47.6 4 0.0245 49.0 5 0.0246 49.2 6 0.0242 48.4 7 0.0244 48.8
[0121] It can be seen from Table 14 above that when ethanol is used as a precipitant, a large amount of sulfachloropyridazine is wrapped by the protein precipitate, resulting in that the cross-linked magnetic chitosan prepared in Example 1 cannot effectively adsorb sulfachloropyridazine.
[0122] (III) Protease hydrolysis
[0123] Accurately weigh 1g of milk in a 10mL colorimetric tube, add 0.5mL100ug / L sulfachloropyridazine standard solution, and weigh 7 groups in parallel for spiked parallel, with a spiked content of 0.05mg / kg; add 5mL of water, then add 1mL50g / L protease solution (the protease used is from CNW brand, with enzyme activity ≥6000U / mg), and culture in a 50°C water bath for 30min. Take out and cool, dilute to 10mL with water, filter, add 100mg of the cross-linked magnetic chitosan prepared in Example 1 to the filtrate, vortex oscillate at 25°C for 20min, discard the supernatant under an external magnet, add 5mL0.1% perchloric acid + methanol solution (volume ratio 19:1) to a centrifuge tube, sonicate at 40°C for 20min, and filter the supernatant through a 0.22μm filter membrane for LC / MS / MS determination. The recovery rate is calculated, and the results are shown in Table 15 below.
[0124] Table 15 Spiked recovery of protein removed by protease hydrolysis
[0125] Serial number Sulfadiazine results (mg / kg) Spiked recovery % 1 0.0431 86.2 2 0.0426 85.2 3 0.0445 89.0 4 0.0429 85.8 5 0.0437 87.4 6 0.0425 85.0 7 0.0434 86.8
[0126] It can be seen from Table 15 above that the recovery rate of the enzymatic hydrolysis method is between 85.2% and 89%, which meets the recovery rate requirements in GB / T 27404-2008 "Laboratory Quality Control Specifications for Physical and Chemical Testing of Foods" and can be used for the determination of sulfachloropyridazine content in milk.
[0127] From the results of the above three experimental schemes, it can be seen that when using commonly used inorganic salt solutions and organic solvents to precipitate proteins, most of the sulfachloropyridazine is wrapped by the protein precipitate and cannot be freed, resulting in a low recovery rate. Protease can hydrolyze large molecular proteins into small molecular amino acids or polypeptides, so that the protein cannot wrap sulfachloropyridazine, thereby improving the recovery rate.
[0128] 5. Adsorption test of different adsorbents
[0129] In the following tests, the specific parameters of LC / MS / MS determination are shown in Tables 1 to 4 above.
[0130] (I) Ordinary chitosan adsorption
[0131] 100 mg of ordinary chitosan and 100 mg of the cross-linked magnetic chitosan prepared in Example 1 were weighed into a 2 mL centrifuge tube, 1 mL of 10 ug / L sulfachloropyridazine standard solution was added to the centrifuge tube respectively, and the mixture was extracted by vortexing at 25° C. for 20 min. The supernatant was filtered through a 0.22 μm organic filter membrane and then subjected to LC / MS / MS determination to obtain the measured concentration of sulfachloropyridazine in the supernatant; the theoretical concentration of the supernatant was 10 ug / L, and the adsorption effects of the two chitosans could be obtained by the ratio of the measured concentration to the theoretical concentration (the higher the measured concentration, the worse the adsorption effect, and vice versa, the better the adsorption effect); the test results are shown in Table 16 below.
[0132] Table 16 Adsorption rate of common chitosan and magnetic chitosan to sulfachloropyridazine
[0133]
[0134] It can be seen from Table 16 above that ordinary chitosan has almost no adsorption capacity for sulfachloropyridazine, while the adsorption rate of the cross-linked magnetic chitosan prepared in Example 1 can reach more than 90%, that is, the cross-linked magnetic chitosan optimized on the basis of ordinary chitosan in the present invention has significantly better adsorption capacity for sulfachloropyridazine than ordinary chitosan.
[0135] (II) Oasis HLB solid phase extraction column
[0136] The Oasis HLB solid phase extraction column was used to conduct an adsorption test on sulfachloropyridazine using the national standard method GB / T22966-2008 "Determination of 16 sulfonamide drug residues in milk and milk powder by liquid chromatography-tandem mass spectrometry". The results showed that the adsorption rate of sulfachloropyridazine was 95%; the adsorption rate of the present application was not much different from that of the standard method test;
[0137] However, the Oasis HLB solid phase extraction column in the national standard method GB / T22966-2008 "Determination of 16 sulfonamide drug residues in milk and milk powder by liquid chromatography-tandem mass spectrometry" is used for adsorption, with a specification of 60 mg, 3 mL. The purchase price of the extraction column is 2,900 yuan / 100 pieces, and the price of each piece is 29 yuan. Each sample requires one extraction column, and the cost is 29 yuan; while the preparation of the cross-linked magnetic chitosan in the present invention requires 0.1 g of ordinary chitosan, and each sample requires 0.1 g of cross-linked magnetic chitosan, that is, each sample requires 0.1 g of ordinary chitosan (the cost of other raw materials is lower than that of ordinary chitosan, and no specific calculation is made here), ordinary chitosan comes from McLean Company, the price is 53 yuan / bottle, the specification of each bottle is 100 g, and 0.1 g is 0.053 yuan, that is, the reagent cost required to prepare 0.1 g of cross-linked chitosan is about 0.5 yuan, and the cost is much lower than 29 yuan of the method used in the existing national standard.
[0138] Finally, it should be noted that the above embodiments are only used to illustrate the technical solution of the present invention rather than to limit it. Although the present invention has been described in detail with reference to the preferred embodiments, those skilled in the art should understand that the technical solution of the present invention can be modified or replaced by equivalents without departing from the purpose and scope of the technical solution of the present invention, which should be covered by the scope of the claims of the present invention.
Claims
1. A magnetic chitosan, characterized in that: The preparation method comprises: (1) mixing an acid solution containing chitosan, Fe 2+ Salt and Fe 3+ The salts are mixed and dissolved to obtain a mixture; (2) the mixture is mixed and reacted with an alkaline solution to obtain a first magnetic chitosan.
2. The magnetic chitosan according to claim 1, characterized in that The preparation method also includes: mixing the first magnetic chitosan with a chitosan crosslinking agent to obtain a second magnetic chitosan.
3. The magnetic chitosan according to claim 2, characterized in that The chitosan cross-linking agent is selected from one or more combinations of glutaraldehyde, formaldehyde and glyoxal.
4. A method for extracting sulfachloropyridazine from milk, characterized in that: include: (1) enzymatically hydrolyzing the milk source to obtain a treated liquid; (2) adding magnetic chitosan to the treated liquid for extraction to obtain an extract containing sulfachloropyridazine; wherein the magnetic chitosan is the magnetic chitosan according to any one of claims 1 to 3.
5. The extraction method according to claim 4, characterized in that Extraction includes: The magnetic chitosan is mixed with the treatment solution, vortexed and shaken, and the supernatant is removed to obtain a residue; the residue is mixed with an eluent, and an extract is eluted to obtain an extract.
6. The extraction method according to claim 5, characterized in that The extraction includes one or more combinations of the following conditions: (a) the eluent is a mixed solution of perchloric acid and methanol; (b) the eluent is a mixed solution of perchloric acid and methanol, wherein the mass fraction of perchloric acid is 0.05%-0.15%; (c) the eluent is a mixed solution of perchloric acid and methanol, wherein the volume ratio of perchloric acid to methanol is (17-21):1; (d) the amount of the magnetic chitosan is 80mg-120mg; (e) The amount of the eluent used is 5 mL-10 mL.
7. The extraction method according to claim 5 or 6, characterized in that The extraction includes one or more combinations of the following conditions: (a) the vortex oscillation time is ≥ 20 min; (b) the temperature of the vortex oscillation is 23° C.-27° C.; (c) the elution comprises: ultrasonically oscillating the mixture of the residue and the eluent, and filtering; the temperature of the ultrasonic oscillation is 40° C.-50° C.; (d) The elution comprises: ultrasonically oscillating the mixture of the residue and the eluent, and filtering; the ultrasonic oscillation time is ≥ 20 min.
8. The extraction method according to any one of claims 4 to 6, characterized in that The enzymatic hydrolysis includes: using protease to perform enzymatic hydrolysis.
9. A method for detecting the content of sulfachloropyridazine in milk, characterized in that: include: (1) extracting milk according to the extraction method described in any one of claims 4 to 8 to obtain an extract containing sulfachloropyridazine; (2) detecting the content of sulfachloropyridazine in the extract containing sulfachloropyridazine.
10. The detection method according to claim 9, characterized in that: The sulfachloropyridazine content of the extract containing sulfachloropyridazine is detected by LC / MS / MS.
Citation Information
Cited By
Composite purification filler and pretreatment method for sulfonamides detection
CN119771373A
